The trailing price-to-earnings (P/E) ratio for Hester Biosciences Limited hovers around 33.17, reflecting market valuations typical of specialized small-cap biotechnology and animal healthcare enterprises. This valuation multiple fluctuates dynamically during active trading sessions based on quarterly net profit reports, earnings per share variations, and broader sentiment shifts across the Indian pharmaceutical sector on the National Stock Exchange and Bombay Stock Exchange.